Evotec divests chemical API-focused CDMO operation in Halle/Westphalia (Evotec DS) to Monacum PartnersTransaction aligns with Evotec's strategic optimization efforts, concentrating...
Vancouver, British Columbia--(Newsfile Corp. - November 4, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the...
DELRAY BEACH, Fla., Nov. 4, 2024 /PRNewswire/ -- The global AI in pathology market is projected to reach USD 169.8 million...
SPRINGFIELD, N.J. and WAYNE, Pa., Nov. 4, 2024 /PRNewswire/ -- Hudson, a global laboratory automation solutions provider, and Argosy Healthcare...
10 groundbreaking startups to pitch at Richmond's Main Street Station on November 20, 2024 RICHMOND, Va., Nov. 4, 2024 /PRNewswire/...
The new multi-million-dollar clean room will allow to increase production capabilities of barrier bottles and improve quality control. ASHDOT YA'ACOV...
ROME, Nov. 4, 2024 /PRNewswire/ -- The plan provides for a targeted strengthening of current assets, with clear objectives of...
The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma channel,...
NEW YORK, Nov. 4, 2024 /PRNewswire/ - Bio-K Plus, a Kerry Company and pioneer in the probiotic sector, is thrilled...
NEWTOWN, Pa., Nov. 4, 2024 /PRNewswire/ -- Catalyx, a global leader in machine vision and automation for highly regulated industries,...
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to...
NEW YORK, Nov. 4, 2024 /PRNewswire/ -- Arsenal Capital Partners ("Arsenal"), a leading private equity firm specializing in building technology-rich,...
The cloud-based platform enhances FibroScan® capabilities, providing advanced tools for data-driven liver disease management PARIS, Nov. 4, 2024 /PRNewswire/ -- Liver...
SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company...
Segment featuring leading Neuro-Oncologist and Glioblastoma Key Opinion Leader, Professor Michael WellerAccess the segment here HOUSTON, TX / ACCESSWIRE /...
Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of...
Experienced CFO and investment banker with 30-year track record will help drive CureVac's transformationTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE...
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 4, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical...
VANCOUVER, Washington, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing...